AMLX logo

Amylyx Pharmaceuticals, Inc. (AMLX) Free cash flow

annual FCF:

-$167.80M-$178.48M(-1671.49%)
December 31, 2024

Summary

  • As of today (September 18, 2025), AMLX annual free cash flow is -$167.80 million, with the most recent change of -$178.48 million (-1671.49%) on December 31, 2024.
  • During the last 3 years, AMLX annual FCF has fallen by -$92.65 million (-123.29%).
  • AMLX annual FCF is now -1671.49% below its all-time high of $10.68 million, reached on December 31, 2023.

Performance

AMLX Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXcash flow metrics

quarterly FCF:

-$25.27M+$14.57M(+36.58%)
June 1, 2025

Summary

  • As of today (September 18, 2025), AMLX quarterly free cash flow is -$25.27 million, with the most recent change of +$14.57 million (+36.58%) on June 1, 2025.
  • Over the past year, AMLX quarterly FCF has increased by +$41.40 million (+62.10%).
  • AMLX quarterly FCF is now -291.47% below its all-time high of $13.20 million, reached on December 31, 2023.

Performance

AMLX quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXcash flow metrics

TTM FCF:

-$201.88M+$41.40M(+17.02%)
June 1, 2025

Summary

  • As of today (September 18, 2025), AMLX TTM free cash flow is -$201.88 million, with the most recent change of +$41.40 million (+17.02%) on June 1, 2025.
  • Over the past year, AMLX TTM FCF has dropped by -$142.33 million (-238.98%).
  • AMLX TTM FCF is now -1407.19% below its all-time high of $15.44 million, reached on March 31, 2024.

Performance

AMLX TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

AMLX Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-1671.5%+62.1%-239.0%
3 y3 years-123.3%+46.9%-128.0%
5 y5 years-1470.2%--

AMLX Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-1671.5%+8.0%-291.5%+67.5%-1407.2%+17.0%
5 y5-year-1671.5%+8.0%-291.5%+67.5%-1407.2%+17.0%
alltimeall time-1671.5%+8.0%-291.5%+67.5%-1407.2%+17.0%

AMLX Free cash flow History

DateAnnualQuarterlyTTM
Jun 2025
-
-$25.27M(-36.6%)
-$201.88M(-17.0%)
Mar 2025
-
-$39.84M(-32.5%)
-$243.29M(+19.3%)
Dec 2024
-$167.80M(-1671.5%)
-$59.03M(-24.1%)
-$204.01M(+54.8%)
Sep 2024
-
-$77.75M(+16.6%)
-$131.78M(+121.3%)
Jun 2024
-
-$66.67M(>+9900.0%)
-$59.56M(-485.6%)
Mar 2024
-
-$556.00K(-104.2%)
$15.44M(+44.6%)
Dec 2023
$10.68M
$13.20M(-338.8%)
$10.68M(-120.2%)
Sep 2023
-
-$5.53M(-166.3%)
-$52.83M(-41.8%)
Jun 2023
-
$8.33M(-256.5%)
-$90.84M(-38.1%)
DateAnnualQuarterlyTTM
Mar 2023
-
-$5.32M(-89.4%)
-$146.74M(-19.5%)
Dec 2022
-$182.40M(+142.7%)
-$50.32M(+15.6%)
-$182.40M(+38.1%)
Sep 2022
-
-$43.54M(-8.5%)
-$132.08M(+49.2%)
Jun 2022
-
-$47.57M(+16.1%)
-$88.54M(+63.9%)
Mar 2022
-
-$40.98M(+214.1%)
-$54.02M(+110.2%)
Dec 2021
-$75.15M(+104.0%)
-
-
Jun 2021
-
-$13.05M(+3.1%)
-$25.70M(+103.1%)
Mar 2021
-
-$12.66M
-$12.66M
Dec 2020
-$36.85M(+244.8%)
-
-
Dec 2019
-$10.69M
-
-

FAQ

  • What is Amylyx Pharmaceuticals, Inc. annual free cash flow?
  • What is the all time high annual FCF for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. annual FCF year-on-year change?
  • What is Amylyx Pharmaceuticals, Inc. quarterly free cash flow?
  • What is the all time high quarterly FCF for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. quarterly FCF year-on-year change?
  • What is Amylyx Pharmaceuticals, Inc. TTM free cash flow?
  • What is the all time high TTM FCF for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. TTM FCF year-on-year change?

What is Amylyx Pharmaceuticals, Inc. annual free cash flow?

The current annual FCF of AMLX is -$167.80M

What is the all time high annual FCF for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high annual free cash flow is $10.68M

What is Amylyx Pharmaceuticals, Inc. annual FCF year-on-year change?

Over the past year, AMLX annual free cash flow has changed by -$178.48M (-1671.49%)

What is Amylyx Pharmaceuticals, Inc. quarterly free cash flow?

The current quarterly FCF of AMLX is -$25.27M

What is the all time high quarterly FCF for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high quarterly free cash flow is $13.20M

What is Amylyx Pharmaceuticals, Inc. quarterly FCF year-on-year change?

Over the past year, AMLX quarterly free cash flow has changed by +$41.40M (+62.10%)

What is Amylyx Pharmaceuticals, Inc. TTM free cash flow?

The current TTM FCF of AMLX is -$201.88M

What is the all time high TTM FCF for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high TTM free cash flow is $15.44M

What is Amylyx Pharmaceuticals, Inc. TTM FCF year-on-year change?

Over the past year, AMLX TTM free cash flow has changed by -$142.33M (-238.98%)
On this page